Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Jan 25, 2025. (Total: 235671Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 7 (of 7 Records)

Query Trace: Breast Neoplasms and CD24[original query]
CD24 Ala57Val polymorphism predicts pathologic complete response to sequential anthracycline- and taxane-based neoadjuvant chemotherapy for primary breast cancer.
Breast cancer research and treatment 2012 Apr 132 (3): 819-31.
Marmé Frederik, Werft Wiebke, Walter Anne, Keller Sascha, Wang Xiaoli, Benner Axel, Burwinkel Barbara, Sinn Peter, Hug Sarah, Sohn Christof, Bretz Niko, Moldenhauer Gerhard, Rupp Christian, Rupp Anne-Kathleen, Biakhov Mikhail Y, Bottini Alberto, Friedrichs Kay, Khailenko V A, Manikhas Georgiy M, Ruiz Amparo, Sánchez-Rovira Pedro, Santoro Armando, Segui Miguel A, Villena Carlos, Lichter Peter, Kristiansen Glen, Altevogt Peter, Schneeweiss Andre
[Association between CD24 polymorphism and genetic susceptibility to breast cancer: a case-control study].
Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences 2013 Nov 38 (11): 11.
Zhou X, Cao Y, Luo J, Zeng X
CD24 polymorphisms in breast cancer: impact on prognosis and risk.
Breast cancer research and treatment 2013 Jan .
Buck K, Hug S, Seibold P, Ferschke I, Altevogt P, Sohn C, Schneeweiss A, Burwinkel B, Jäger D, Flesch-Janys D, Chang-Claude J, Marmé F
CD24 single nucleotide polymorphisms and cancer risk.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2014 Sep 35 (9): 8927-32.
Yan Shushan, Xu Donghua, Jiang Tao, Wang Ping, Yin Yin, Wang Xiaochen, Hua Changjiang, Zhang Bin, Li Zengcai, Lu Lei, Liu Xianzhong, Wang Bingji, Zhang Donghua, Zhang Rongsheng, Sun Beicheng, Wang Xu
CD24 polymorphisms cannot predict pathologic complete response to anthracycline- and taxane-based neoadjuvant chemotherapy in breast cancer.
Clinical breast cancer 2014 Apr 14 (2): e33-40.
Zhou X
Stathmin1 expression is associated with aggressive phenotypes and cancer stem cell marker expression in breast cancer patients.
International journal of oncology 2017 Sep 51 (3): 781-790.
Obayashi Sayaka, Horiguchi Jun, Higuchi Toru, Katayama Ayaka, Handa Tadashi, Altan Bolag, Bai Tuya, Bao Pinjie, Bao Halin, Yokobori Takehiko, Nishiyama Masahiko, Oyama Tetsunari, Kuwano Hiroyu
Identification of a 6-gene signature for the survival prediction of breast cancer patients based on integrated multi-omics data analysis.
PloS one 2020 11 15 (11): e0241924.
Mo Wenju, Ding Yuqin, Zhao Shuai, Zou Dehong, Ding Xiaow
TOP